Cross-reactivity of influenza A (H3N2) hemagglutination-inhibition antibodies induced by an inactivated influenza vaccine

Vaccine

Volumn 24, Issue 33-34, 2006, Pages 5966-5969

  Kojimahara, Noriko ^a   Maeda, Akiko ^b   Kase, Tetsuo ^c   Yamaguchi, Naohito ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Osaka Prefecture University   (Japan)

^c OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Elderly; Hemagglutination inhibition antibody; Influenza vaccine

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS REACTION; FEMALE; HEMAGGLUTINATION; HUMAN; INFLUENZA; INFLUENZA VIRUS; INFORMED CONSENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VACCINATION;

AGED; ANTIBODIES, VIRAL; CROSS REACTIONS; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; MALE; MIDDLE AGED; VACCINES, INACTIVATED;

EID: 33746044890     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.05.009     Document Type: Article

References (17)

1. Kilbourne E.D. Influenza (1987), Plenum Medical Book Company, New York, NY
2. Odagiri T, Tashiro M. The selection passage of 2003-2004 season influenza vaccine. IASR 2003;24:215-17 (in Japanese).
3. CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 53 (2004) 1-40
4. Hirota Y., Kaji M., Ide S., Kajiwara J., Kataoka K., Goto S., et al. Antibody efficacy as a keen index to evaluate influenza vaccine effectiveness. Vaccine 15 (1997) 962-967
5. Lennette E.H., and Schmidt N.J. Hemagglitination-inhibition test, diagnostic procedures for viral, rickettsial and chlamydial infections. 5th ed. (1979), American Public Health Association p. 603
6. National Institute of Health. Experimental virology (1973), Maruzen, Tokyo, Japan p. 217-25 (in Japanese)
7. Maeda A., and Kase t. Evalation of antibodies to influenza viruses. Sogo Rinsho 54 (2005) 305-310 (in Japanese)
8. WHO. Collaborating center for influenza and respiratory viruses Japan: protocol for HAI indentification of field strains (1997), National Institute of Infectious Disease Laboratory of Respiratory Viruses, Tokyo
9. http://idsc.nih.go.jp/iasr/24/285/graph/df28513.pdf#search='phylogenetic%20analysis%20influenza
10. Hirota Y., Kaji M., Ide S., Kajiwara J., Goto S., and Oka T. The hemagglunitination inhibition antibody responses to an inactivated influenza vaccine among healthy adult: with special reference to the prevaccination antibody and its interaction with age. Vaccine 14 (1996) 1597-1602
11. Patriarca P.A., Weber J.A., Parker R.A., et al. Risk factors for outbreaks of influenza in nursing homes: a case-control study. Am J Epidemiol 124 (1986) 114-119
12. Nordin J., Mullooly J., Poblete S., et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from three health plans. J Infect Dis 184 (2001) 665-670
13. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., and Levandowski R.A. Efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med 123 (1995) 518-527
14. Mullooly J.P., Bennett M.D., Hornbrook M.C., et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 121 (1994) 947-952
15. Pozzetto B., Odeline M.F., Bievenu J., Defayolle M., and Aymard M. Is there a relationship between malnutrion, inflammation, and post-vaccinal antibody response to influenza viruses in the elderly?. J Med Virol 41 (1993) 39-43
16. Gardner E.M., Bernstein E.D., Dorfman M., Abrutyn E., and Murasko D.M. The age-associated decline in immune function of healthy individuals is not related to changes in plasma concentrations of beta-carotene, retinol, alpha-tocopherol or zinc. Mech Age Dev 94 (1997) 55-69
17. Kojimahara N., and Yamaguchi N. The efficacy of influenza vaccination and serum antibody. Igakunoayumi 211 (2004) 1088-1089 (in Japanese)